These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20586509)

  • 1. A patient with psoriasis and vitiligo treated with etanercept.
    Campanati A; Giuliodori K; Ganzetti G; Liberati G; Offidani AM
    Am J Clin Dermatol; 2010; 11 Suppl 1():46-8. PubMed ID: 20586509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept therapy for psoriasis in a patient with numerous comorbidities.
    De Simone C; Carbone A; Caldarola G
    Am J Clin Dermatol; 2010; 11 Suppl 1():49-50. PubMed ID: 20586510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept in a patient with severe psoriasis and latent viral hepatic disease and latent tuberculosis.
    Prestinari F; Ferguglia G; Laria G
    Am J Clin Dermatol; 2010; 11 Suppl 1():57-8. PubMed ID: 20586514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etanercept therapy for psoriasis in a patient with active pulmonary tuberculosis.
    Huo R; Romanelli P
    Am J Clin Dermatol; 2010; 11 Suppl 1():39-40. PubMed ID: 20586506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of severe psoriasis with an apparent incomplete response to anti-tumour necrosis factor alpha treatment.
    Agnusdei CP; Mastronardi C
    Am J Clin Dermatol; 2010; 11 Suppl 1():41-3. PubMed ID: 20586507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of generalized vitiligo with anti-TNF-α Agents.
    Alghamdi KM; Khurrum H; Taieb A; Ezzedine K
    J Drugs Dermatol; 2012 Apr; 11(4):534-9. PubMed ID: 22453596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing pediatric patients with psoriasis.
    Bard S; Torchia D; Schachner LA
    Am J Clin Dermatol; 2010; 11 Suppl 1():15-7. PubMed ID: 20586500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of dystrophic epidermolysis bullosa improved with etanercept for concomitant psoriatic arthritis.
    Gubinelli E; Angelo C; Pacifico V
    Am J Clin Dermatol; 2010; 11 Suppl 1():53-4. PubMed ID: 20586512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
    Cecchi R; Bartoli L
    Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of lymphocyte populations in psoriatic plaques following inhibition of tumor necrosis factor alpha with etanercept].
    Mahiques L; Pitarch G; Sánchez-Carazo JL; Pérez-Ferriols A; Soriano CJ; Alegre V
    Actas Dermosifiliogr; 2007 Oct; 98(8):539-44. PubMed ID: 17919428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of etanercept in children and adolescents aged > or = 8 years with severe plaque psoriasis.
    Landells I; Paller AS; Pariser D; Kricorian G; Foehl J; Molta C; Freundlich B
    Eur J Dermatol; 2010; 20(3):323-8. PubMed ID: 20185386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
    Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
    Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
    Gandhi RK; Pickup T; Sheth PB
    Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of erythrodermic psoriasis with etanercept.
    Esposito M; Mazzotta A; de Felice C; Papoutsaki M; Chimenti S
    Br J Dermatol; 2006 Jul; 155(1):156-9. PubMed ID: 16792768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study.
    Gisondi P; Cotena C; Tessari G; Girolomoni G
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):341-4. PubMed ID: 18005022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept.
    Daulat S; Detweiler JG; Pandya AG
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):483-4. PubMed ID: 18793242
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report.
    Skroza N; Proietti I; Bernardini N; La Viola G; Nicolucci F; Tolino E; Zuber S; Potenza C
    Cutis; 2012 Sep; 90(3):120-2. PubMed ID: 23094309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.